Identification and mapping of post-transcriptional modifications on the HIV-1 antisense transcript Ast in human cells

RNA. 2022 May;28(5):697-710. doi: 10.1261/rna.079043.121. Epub 2022 Feb 15.

Abstract

The human immunodeficiency virus type 1 (HIV-1) encodes multiple RNA molecules. Transcripts that originate from the proviral 5' long terminal repeat (LTR) function as messenger RNAs for the expression of 16 different mature viral proteins. In addition, HIV-1 expresses an antisense transcript (Ast) from the 3'LTR, which has both protein-coding and noncoding properties. While the mechanisms that regulate the coding and noncoding activities of Ast remain unknown, post-transcriptional modifications are known to influence RNA stability, interaction with protein partners, and translation capacity. Here, we report the nucleoside modification profile of Ast obtained through liquid chromatography coupled with mass spectrometry (LC-MS) analysis. The epitranscriptome includes a limited set of modified nucleosides but predominantly ribose methylations. A number of these modifications were mapped to specific positions of the sequence through RNA modification mapping procedures. The presence of modifications on Ast is consistent with the RNA-modifying enzymes interacting with Ast The identification and mapping of Ast post-transcriptional modifications is expected to elucidate the mechanisms through which this versatile molecule can carry out diverse activities in different cell compartments. Manipulation of post-transcriptional modifications on the Ast RNA may have therapeutic implications.

Keywords: HIV-1; RNA modification mapping; antisense RNA; epitranscriptomics; nucleoside analysis.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Chromatography, Liquid
  • HIV-1* / genetics
  • HIV-1* / metabolism
  • Humans
  • Nucleosides / metabolism
  • RNA Processing, Post-Transcriptional
  • RNA, Antisense / genetics
  • Terminal Repeat Sequences

Substances

  • Nucleosides
  • RNA, Antisense